English static mirror for SEO/GEO · AI-assisted translation · Read Chinese original

Review of 'Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study' (Liu, Zhu, Tian; Cancer Medicine, 2022) — Concerns of methodological copy-paste, failed PSM, and abnormal publication timeline

Academic fraud report · Geng Detector

Summary

This report raises significant methodological and editorial concerns about the paper 'Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study' (DOI: 10.1002/cam4.4611) published in Cancer Medicine in 2022. The verdict is 'Questionable' (yellow flag). Three main issues are identified. First, the Statistical analysis section states that 'SPSS 11.0' was used; this software dates from 2001–2002, strongly suggesting that the methods paragraph was copy-pasted from an older paper without updating the version. Second, the publication timeline shows Received 21 Nov 2021, Revised 22 Dec 2021, Accepted 23 Dec 2021 — only one day between revision and acceptance, which is highly unusual and raises doubts about the rigor of peer review. Third, the authors claim that propensity-score matching (PSM) balanced baseline covariates, yet Table 2 after PSM shows p < 0.001 for both Grade and SEER stage, meaning the two most important prognostic variables were not actually balanced; the authors nevertheless proceeded to Cox and survival analyses. No image manipulation could be tested because the study contains no original Western blot or microscopy images. These findings are indicative of a 'template-based' SEER data-mining paper and warrant editorial investigation.

Verdict

🟡 Questionable. The paper shows strong signs of being a template-based SEER data-mining study with serious methodological inconsistencies, a failed covariate-balancing procedure that is glossed over, and an implausibly rapid revision-to-acceptance window. The cumulative pattern warrants editorial scrutiny, although the authors have not been formally proven guilty of misconduct.

Key findings

  • Anachronistic software version (Section 2.5, Statistical analysis, Page 2218): The Methods state that analyses were performed using *SPSS 11.0*. SPSS 11.0 was released by SPSS Inc. around 2001–2002. For a manuscript submitted in late 2021, citing a ~20-year-old software version is highly implausible and is a typical fingerprint of a copy-pasted Methods section from an earlier publication.
  • Abnormally rapid peer review (Page 2216):
  • Received: 21 November 2021
  • Revised: 22 December 2021
  • Accepted: 23 December 2021
  • Revision-to-acceptance gap: 1 day. This is inconsistent with normal peer-review workflows, which require re-review or at least editorial scrutiny over days to weeks. Either the revised manuscript was accepted without re-review or the dates were back-filled.
  • Failed propensity-score matching (Table 2, Page 2220; Results, Page 2219): Although the authors claim PSM was performed to balance baseline characteristics between carcinosarcoma (CS) and transitional cell carcinoma (TCC), Table 2 post-PSM still shows:
  • Grade: p < 0.001
  • SEER stage: p < 0.001
  • Both of these are among the most important prognostic variables in bladder cancer. A non-significant balance check would be expected; instead, the matching completely failed to balance these covariates, yet the authors proceeded with Cox regression and survival analyses as if matching had succeeded.
  • No image-manipulation evidence (full text): No Western blots, gels, or microscopy images are present; the article is a pure SEER database ('dry-lab') study with only software-generated Kaplan–Meier curves and forest plots. Image-based fraud checks are therefore inapplicable, which lowers the cost and detectability of fabrication.
  • Evidence highlights

  • Quantitative evidence preserved from the source:
  • p < 0.001 for Grade after PSM (Table 2)
  • p < 0.001 for SEER stage after PSM (Table 2)
  • Revision date: 22 December 2021
  • Acceptance date: 23 December 2021 (Δ = 1 day)
  • Software declared: SPSS 11.0 (released ~2001–2002)
  • DOI: 10.1002/cam4.4611
  • Notes

  • The SPSS 11.0 finding alone could in principle be a typographical mistake rather than deliberate copy-paste, but combined with the failed PSM and the one-day acceptance, it forms a coherent pattern of low-rigor, template-based production.
  • The failed PSM is not necessarily intentional fraud; it could reflect author incompetence in interpreting matching diagnostics. However, reporting 'PSM balanced the cohorts' when p < 0.001 persists for the central prognostic variables is a substantive methodological error that materially affects the validity of downstream hazard-ratio estimates.
  • The 1-day revision-to-acceptance gap is best characterized as an editorial-process anomaly rather than proven misconduct; it requires confirmation from the journal's editorial records.
  • No findings in this report constitute definitive proof of data fabrication. All conclusions should be treated as concerns that warrant investigation by the editorial office and, if needed, the authors' institution.
  • Suggested follow-ups: request raw analysis code from the authors, post a PubPeer comment focused on the PSM failure, and notify the journal of the timeline and software-version inconsistencies.

Tags

#academic-fraud#seer-data-mining#propensity-score-matching#methodology-issues#peer-review-anomaly#cancer-medicine#bladder-cancer#copy-paste-suspected

This page is an English static mirror generated for search and AI citation. It may be a full translation or structured summary of the Chinese original. Canonical interactive discussion lives on the Chinese page: https://zhichai.net/report/geng_geng_6a1e7723f21892.58124126